We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+18.1%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$1.52B
AUM Growth
+$95.3M
Cap. Flow
-$53M
Cap. Flow %
-3.48%
Top 10 Hldgs %
46.4%
Holding
811
New
169
Increased
201
Reduced
172
Closed
223

Sector Composition

Rank Sector Weight
1 Healthcare 30.8%
2 Financials 24.54%
3 Technology 21.73%
4 Communication Services 4.41%
5 Energy 3.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SATLW icon
251
Satellogic Inc Warrant
SATLW
$100M
$81K 0.01%
+982,380
New +$108K
MSAIW icon
252
MultiSensor AI Holdings Warrant
MSAIW
$751K
$80.1K 0.01%
1,741,201
+117,438
+7% +$4.6K
AILEW
253
DELISTED
iLearningEngines, Inc. Warrant
AILEW
$77K 0.01%
950,022
+189,516
+25% +$17K
EVLVW
254
DELISTED
Evolv Technologies Warrant
EVLVW
$72.9K ﹤0.01%
95,932
+5,300
+6% +$3.42K
UHGWW
255
DELISTED
United Homes Group Warrant
UHGWW
$70.8K ﹤0.01%
73,223
-87,388
-54% -$71.6K
BNKK
256
Bonk Inc
BNKK
$8.48M
$70.2K ﹤0.01%
+571
New +$53.8K
NVACR
257
DELISTED
NorthView Acquisition Corporation Rights
NVACR
$70.1K ﹤0.01%
804,257
+72,975
+10% +$8.39K
GRND.WS
258
DELISTED
Grindr Inc. Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
GRND.WS
$68.9K ﹤0.01%
38,056
+4,555
+14% +$5.54K
USARW
259
DELISTED
USA Rare Earth Inc Warrant
USARW
$68.4K ﹤0.01%
759,514
+573,311
+308% +$82.4K
RVMDW icon
260
Revolution Medicines Inc Warrant
RVMDW
$128M
$66K ﹤0.01%
+199,900
New +$89.3K
LAC
261
Lithium Americas
LAC
$1.17B
$64K ﹤0.01%
+10,000
New +$74.5K
PROCW
262
DELISTED
Procaps Group, S.A. Warrants
PROCW
$63.7K ﹤0.01%
495,000
-13,900
-3% -$1.22K
ARIZR
263
DELISTED
Arisz Acquisition Corp. Right
ARIZR
$62.4K ﹤0.01%
297,115
-493,985
-62% -$50.9K
LCAAW
264
DELISTED
L Catterton Asia Acquisition Corp Warrant
LCAAW
$62.3K ﹤0.01%
92,950
-460,016
-83% -$240K
BAERW icon
265
Bridger Aerospace Warrant
BAERW
$12.3M
$61.9K ﹤0.01%
292,804
-34,184
-10% -$7.29K
KITTW icon
266
Nauticus Robotics Warrant
KITTW
$205K
$60.7K ﹤0.01%
1,160,104
+263,262
+29% +$42.9K
BHACW
267
DELISTED
Focus Impact BH3 Acquisition Company Warrants
BHACW
$59.7K ﹤0.01%
995,254
+932,632
+1,489% +$37.4K
BAYAR
268
DELISTED
Bayview Acquisition Corp Right
BAYAR
$59.5K ﹤0.01%
+496,171
New +$59.5K
PHYT.WS
269
DELISTED
Pyrophyte Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
PHYT.WS
$56.8K ﹤0.01%
709,953
+612,253
+627% +$46K
SLGCW
270
DELISTED
SomaLogic, Inc. Warrant
SLGCW
$56.1K ﹤0.01%
+467,501
New +$66.6K
CNDA.WS
271
DELISTED
Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
CNDA.WS
$55.3K ﹤0.01%
425,368
+175,352
+70% +$28.9K
BOWNR
272
DELISTED
Bowen Acquisition Corp Rights
BOWNR
$55.2K ﹤0.01%
502,268
+531
+0.1% +$76
CYCUW
273
Cycurion Inc Warrant
CYCUW
$267K
$53.3K ﹤0.01%
1,672,355
+71,924
+4% +$4.03K
KVACW
274
DELISTED
Keen Vision Acquisition Corp Warrant
KVACW
$53.1K ﹤0.01%
1,327,136
+260,067
+24% +$11.5K
SLND.WS icon
275
Southland Holdings Warrants
SLND.WS
$1.28M
$52K ﹤0.01%
+123,811
New +$59.6K

Similar funds

Cowen and Company's Q4 2023 Portfolio in Review

As of Q4 2023, Cowen and Company held 811 positions worth $1.52B, up 6.7% from $1.43B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Cowen and Company withdrew a net $53M in Q4 2023, closing 223 positions and reducing 172 holdings. Its most notable exit was AdvisorShares Pure US Cannabis ETF, an estimated $48.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 22% a quarter earlier, followed by Financials and Technology.

Against the trend, Cowen and Company opened a new position in Sage Therapeutics worth $29M.

  • Cowen and Company's largest Q4 2023 buy was Sage Therapeutics: 1,339,971 shares worth $29M.
  • Cowen and Company added most to PTC Therapeutics in Q4 2023, an estimated $66.9M increase.
  • Cowen and Company's biggest Q4 2023 reduction was Nabors Energy Transition Corp II, cutting an estimated $16.9M.
  • Cowen and Company fully exited AdvisorShares Pure US Cannabis ETF in Q4 2023, selling an estimated $48.7M.
  • Cowen and Company's ten largest holdings make up 46% of its $1.52B portfolio in Q4 2023.
  • Cowen and Company opened 169 new positions and closed 223 in Q4 2023.
  • Cowen and Company's portfolio value rose 6.7% quarter-over-quarter to $1.52B.

Based on Cowen and Company's 13F filing for Q4 2023, filed 8 Feb 2024.